AI assistant
Sending…
Cipla Ltd. — Financial Supplement Data 2022
Apr 11, 2022
Preview isn't available for this file type.
Download source fileRegulation 31(4)- Annual Declar
| Disclosure regulation | Symbol | Name of the Company | Name of the Entity/Person | Category | Financial Year End |
|---|---|---|---|---|---|
| Reg 31(4) | CIPLA | Cipla Limited | Dr. Y. K. Hamied | Promoter | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Mr. M. K. Hamied | Promoter | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Farida Hamied | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Sophie Ahmed | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Shirin Hamied | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Kamil Hamied | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Samina Hamied | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Rumana Hamied | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | MN Rajkumar Garments LLP | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Shree Riddhi Chemicals LLP | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Alps Remedies Private Limited | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Hamsons Laboratories LLP | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Okasa Pharma Private Limited | Promoter Group | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Sara Ahmed | Person Acting in Concert (PAC) | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Farah Barua | Person Acting in Concert (PAC) | 31-Mar-2022 |
| Reg 31(4) | CIPLA | Cipla Limited | Monisha Ahmed | Person Acting in Concert (PAC) | 31-Mar-2022 |
More from Cipla Ltd.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Call Transcript
2026
May 15
Call Transcript
2026
May 15
Report Publication Announcement
2026
May 14
Report Publication Announcement
2026
May 14
Share Issue/Capital Change
2026
May 14
Share Issue/Capital Change
2026
May 14
Regulatory Filings
2026
May 13
Report Publication Announcement
2026
May 13